Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 118 $ 40,770,504 $ (16,289,077) $ 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (decrease) in stockholders' equity        
Shares issued upon exercise of warrants, net of issuance costs $ 21 9,703,609   9,703,630
Shares issued upon exercise of warrants, net of issuance costs (in shares) 2,156,322      
Stock-based compensation: Common stock $ 3 993,044   993,047
Stock-based compensation: Common stock (in shares) 238,702      
Stock-based compensation: Options   23,390   23,390
Common stock issued upon exercise of options   8,361   8,361
Common stock issued upon exercise of options (in shares) 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999   532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Net loss     (10,291,713) (10,291,713)
Balance at the end at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the end (in shares) at Dec. 31, 2021 14,253,948      
Increase (decrease) in stockholders' equity        
Surrender and cancellation of common stock   (54,871)   (54,871)
Surrender and cancellation of common stock (in shares) (11,720)      
Stock-based compensation: Common stock $ 2 1,020,091   1,020,093
Stock-based compensation: Common stock (in shares) 213,807      
Stock-based compensation: Options   8,840   8,840
Net loss     (13,619,884) (13,619,884)
Balance at the end at Dec. 31, 2022 $ 145 $ 53,004,967 $ (40,200,674) $ 12,804,438
Balance at the end (in shares) at Dec. 31, 2022 14,456,035